-
1
-
-
0035845511
-
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
-
Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869–74.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 10869-10874
-
-
Sorlie, T.1
Perou, C.M.2
Tibshirani, R.3
-
2
-
-
0042838307
-
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
-
Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003;100:10393–8.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 10393-10398
-
-
Sotiriou, C.1
Neo, S.Y.2
McShane, L.M.3
-
3
-
-
70349119837
-
Triple negative breast cancers: Clinical and prognostic implications
-
Dawson SJ, Provenzano E, Caldas C. Triple negative breast cancers: clinical and prognostic implications. Eur j Cancer 2009;45(suppl 1):27–40.
-
(2009)
Eur J Cancer
, vol.45
, pp. 27-40
-
-
Dawson, S.J.1
Provenzano, E.2
Caldas, C.3
-
4
-
-
70849122251
-
Triple-negative breast cancer—current status and future directions
-
Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U, Harbeck N. Triple-negative breast cancer—current status and future directions. Ann Oncol 2009;20:1913–27.
-
(2009)
Ann Oncol
, vol.20
, pp. 1913-1927
-
-
Gluz, O.1
Liedtke, C.2
Gottschalk, N.3
Pusztai, L.4
Nitz, U.5
Harbeck, N.6
-
5
-
-
0035751675
-
Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18
-
Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001;30:96–102.
-
(2001)
J Natl Cancer Inst Monogr
, vol.30
, pp. 96-102
-
-
Wolmark, N.1
Wang, J.2
Mamounas, E.3
Bryant, J.4
Fisher, B.5
-
6
-
-
33745670605
-
Primary systemic therapy of breast cancer
-
Sachelarie I, Grossbard ML, Chadha M, Feldman S, Ghesani M, Blum RH. Primary systemic therapy of breast cancer. Oncologist 2006;11:574–89.
-
(2006)
Oncologist
, vol.11
, pp. 574-589
-
-
Sachelarie, I.1
Grossbard, M.L.2
Chadha, M.3
Feldman, S.4
Ghesani, M.5
Blum, R.H.6
-
7
-
-
17444454498
-
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
-
Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483–93.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2483-2493
-
-
Fisher, B.1
Brown, A.2
Mamounas, E.3
-
8
-
-
0035890633
-
Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
-
van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001;19:4224–37.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4224-4237
-
-
Van Der Hage, J.A.1
Van De Velde, C.J.2
Julien, J.P.3
Tubiana-Hulin, M.4
Vandervelden, C.5
Duchateau, L.6
-
9
-
-
41649102048
-
Response to neoadjuvant therapy and long-term survival in patients with triplenegative breast cancer
-
Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triplenegative breast cancer. J Clin Oncol 2008;26:1275–81.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1275-1281
-
-
Liedtke, C.1
Mazouni, C.2
Hess, K.R.3
-
10
-
-
77954576948
-
Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
-
Colleoni M, Cole BF, Viale G, et al. Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Clin Oncol 2010;28:2966–73.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2966-2973
-
-
Colleoni, M.1
Cole, B.F.2
Viale, G.3
-
11
-
-
84949976531
-
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy
-
Prat A, Fan C, Fernandez A, et al. Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy. BMC Med 2015;13:303.
-
(2015)
BMC Med
, vol.13
, pp. 303
-
-
Prat, A.1
Fan, C.2
Fernandez, A.3
-
12
-
-
84862303759
-
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes
-
von Minckwitz G, Untch M, Blohmer JU, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012;30:1796–804.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1796-1804
-
-
Von Minckwitz, G.1
Untch, M.2
Blohmer, J.U.3
-
13
-
-
0034931803
-
Activated human neutrophils release hepatocyte growth factor/scatter factor
-
McCourt M, Wang JH, Sookhai S, Redmond HP. Activated human neutrophils release hepatocyte growth factor/scatter factor. Eur J Surg Oncol 2001;27:396–403.
-
(2001)
Eur J Surg Oncol
, vol.27
, pp. 396-403
-
-
McCourt, M.1
Wang, J.H.2
Sookhai, S.3
Redmond, H.P.4
-
14
-
-
79956329617
-
Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer
-
Mahmoud SM, Paish EC, Powe DG, et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011;29:1949–55.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1949-1955
-
-
Mahmoud, S.M.1
Paish, E.C.2
Powe, D.G.3
-
15
-
-
84925498897
-
High neutrophil-tolymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer
-
Rossi L, Santoni M, Crabb SJ, et al. High neutrophil-tolymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer. Ann Surg Oncol 2015;22:1377–84.
-
(2015)
Ann Surg Oncol
, vol.22
, pp. 1377-1384
-
-
Rossi, L.1
Santoni, M.2
Crabb, S.J.3
-
16
-
-
84905164478
-
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis
-
dju124
-
Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106:dju124.
-
(2014)
J Natl Cancer Inst
, pp. 106
-
-
Templeton, A.J.1
McNamara, M.G.2
Seruga, B.3
-
17
-
-
84856679198
-
Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients
-
Azab B, Bhatt VR, Phookan J, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 2012;19:217–24.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 217-224
-
-
Azab, B.1
Bhatt, V.R.2
Phookan, J.3
-
18
-
-
84934441600
-
Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer
-
Koh CH, Bhoo-Pathy N, Ng KL, et al. Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 2015;113:150–8.
-
(2015)
Br J Cancer
, vol.113
, pp. 150-158
-
-
Koh, C.H.1
Bhoo-Pathy, N.2
Ng, K.L.3
-
19
-
-
84876095247
-
Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients
-
Noh H, Eomm M, Han A. Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer 2013;16:55–9.
-
(2013)
J Breast Cancer
, vol.16
, pp. 55-59
-
-
Noh, H.1
Eomm, M.2
Han, A.3
-
20
-
-
84856670885
-
Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response
-
Fisher CS, Ma CX, Gillanders WE, et al. Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response. Ann Surg Oncol 2012;19:253–8.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 253-258
-
-
Fisher, C.S.1
Ma, C.X.2
Gillanders, W.E.3
-
21
-
-
33847063053
-
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
-
Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 2007;13:2329–34.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2329-2334
-
-
Carey, L.A.1
Dees, E.C.2
Sawyer, L.3
-
22
-
-
84888633713
-
Inf lammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
-
Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inf lammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013;13:759–71.
-
(2013)
Nat Rev Cancer
, vol.13
, pp. 759-771
-
-
Elinav, E.1
Nowarski, R.2
Thaiss, C.A.3
Hu, B.4
Jin, C.5
Flavell, R.A.6
-
23
-
-
41549114264
-
A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer
-
Chanrion M, Negre V, Fontaine H, et al. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer. Clin Cancer Res 2008;14:1744–52.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 1744-1752
-
-
Chanrion, M.1
Negre, V.2
Fontaine, H.3
-
24
-
-
84933181457
-
Role of inflammatory infiltrates in triple negative breast cancer
-
Matsumoto H, Koo SL, Dent R, Tan PH, Iqbal J. Role of inflammatory infiltrates in triple negative breast cancer. J Clin Pathol 2015;68:506–10.
-
(2015)
J Clin Pathol
, vol.68
, pp. 506-510
-
-
Matsumoto, H.1
Koo, S.L.2
Dent, R.3
Tan, P.H.4
Iqbal, J.5
-
25
-
-
84907210556
-
Host antitumor immunity plays a role in the survival of patients with newly diagnosed triple-negative breast cancer
-
Loi S. Host antitumor immunity plays a role in the survival of patients with newly diagnosed triple-negative breast cancer. J Clin Oncol 2014;32:2935–7.
-
(2014)
J Clin Oncol
, vol.32
, pp. 2935-2937
-
-
Loi, S.1
-
26
-
-
84868093750
-
Nsaid analgesic ketorolac used perioperatively may suppress early breast cancer relapse: Particular relevance to triple negative subgroup
-
Retsky M, Rogers R, Demicheli R, et al. nsaid analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat 2012;134:881–8.
-
(2012)
Breast Cancer Res Treat
, vol.134
, pp. 881-888
-
-
Retsky, M.1
Rogers, R.2
Demicheli, R.3
-
27
-
-
84865191854
-
Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
-
Ono M, Tsuda H, Shimizu C, et al. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat 2012;132:793–805.
-
(2012)
Breast Cancer Res Treat
, vol.132
, pp. 793-805
-
-
Ono, M.1
Tsuda, H.2
Shimizu, C.3
-
28
-
-
84884156891
-
The systemic inflammation-based neutrophil– lymphocyte ratio: Experience in patients with cancer
-
Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil– lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 2013;88:218–30.
-
(2013)
Crit Rev Oncol Hematol
, vol.88
, pp. 218-230
-
-
Guthrie, G.J.1
Charles, K.A.2
Roxburgh, C.S.3
Horgan, P.G.4
McMillan, D.C.5
Clarke, S.J.6
-
29
-
-
43049133286
-
The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer
-
Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007;73:215–20.
-
(2007)
Oncology
, vol.73
, pp. 215-220
-
-
Yamanaka, T.1
Matsumoto, S.2
Teramukai, S.3
Ishiwata, R.4
Nagai, Y.5
Fukushima, M.6
-
30
-
-
84880314861
-
Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
-
Wang DS, Luo HY, Qiu MZ, et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 2012;29:3092–100.
-
(2012)
Med Oncol
, vol.29
, pp. 3092-3100
-
-
Wang, D.S.1
Luo, H.Y.2
Qiu, M.Z.3
-
31
-
-
24344442821
-
Neutrophil– lymphocyte ratio as a prognostic factor in colorectal cancer
-
Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil– lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181–4.
-
(2005)
J Surg Oncol
, vol.91
, pp. 181-184
-
-
Walsh, S.R.1
Cook, E.J.2
Goulder, F.3
Justin, T.A.4
Keeling, N.J.5
-
32
-
-
84929158217
-
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
-
Pistelli M, De Lisa M, Ballatore Z, et al. Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients. BMC Cancer 2015;15:195.
-
(2015)
BMC Cancer
, vol.15
, pp. 195
-
-
Pistelli, M.1
De Lisa, M.2
Ballatore, Z.3
-
33
-
-
84944909050
-
Elevated preoperative neutrophilto- lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer
-
Hong J, Mao Y, Chen X, et al. Elevated preoperative neutrophilto- lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer. Tumour Biol 2016;37:4135–42.
-
(2016)
Tumour Biol
, vol.37
, pp. 4135-4142
-
-
Hong, J.1
Mao, Y.2
Chen, X.3
-
34
-
-
0037180757
-
Inflammation and cancer
-
Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–7.
-
(2002)
Nature
, vol.420
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
35
-
-
40349094954
-
Inflammation and breast cancer. Balancing immune response: Crosstalk between adaptive and innate immune cells during breast cancer progression
-
DeNardo DG, Coussens LM. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 2007;9:212.
-
(2007)
Breast Cancer Res
, vol.9
, pp. 212
-
-
Denardo, D.G.1
Coussens, L.M.2
-
36
-
-
79954657385
-
Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
-
Kuang DM, Zhao Q, Wu Y, et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol 2011;54:948–55.
-
(2011)
J Hepatol
, vol.54
, pp. 948-955
-
-
Kuang, D.M.1
Zhao, Q.2
Wu, Y.3
-
37
-
-
0023637126
-
Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha–induced changes in circulating numbers of neutrophils and lymphocytes
-
Ulich TR, del Castillo J, Keys M, Granger GA, Ni RX. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha–induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol 1987;139:3406–15.
-
(1987)
J Immunol
, vol.139
, pp. 3406-3415
-
-
Ulich, T.R.1
Del Castillo, J.2
Keys, M.3
Granger, G.A.4
Ni, R.X.5
-
38
-
-
67649304466
-
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
-
Teramukai S, Kitano T, Kishida Y, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 2009;45:1950–8.
-
(2009)
Eur J Cancer
, vol.45
, pp. 1950-1958
-
-
Teramukai, S.1
Kitano, T.2
Kishida, Y.3
-
39
-
-
0023231451
-
Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system
-
El-Hag A, Clark RA. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol 1987;139:2406–13.
-
(1987)
J Immunol
, vol.139
, pp. 2406-2413
-
-
El-Hag, A.1
Clark, R.A.2
-
40
-
-
79955809907
-
Exocytosis of azurophil and arginase 1–containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation
-
Rotondo R, Bertolotto M, Barisione G, et al. Exocytosis of azurophil and arginase 1–containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation. J Leukoc Biol 2011;89:721–7.
-
(2011)
J Leukoc Biol
, vol.89
, pp. 721-727
-
-
Rotondo, R.1
Bertolotto, M.2
Barisione, G.3
-
41
-
-
0035953308
-
Ifngamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity
-
Shankaran V, Ikeda H, Bruce AT, et al. ifngamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410:1107–11.
-
(2001)
Nature
, vol.410
, pp. 1107-1111
-
-
Shankaran, V.1
Ikeda, H.2
Bruce, A.T.3
-
42
-
-
84874371112
-
Preoperative neutrophil to lymphocyte ratio > 5 is a prognostic factor for recurrent colorectal cancer
-
Mallappa S, Sinha A, Gupta S, Chadwick SJ. Preoperative neutrophil to lymphocyte ratio > 5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis 2013;15:323–8.
-
(2013)
Colorectal Dis
, vol.15
, pp. 323-328
-
-
Mallappa, S.1
Sinha, A.2
Gupta, S.3
Chadwick, S.J.4
-
43
-
-
84945544960
-
Predictive value of neutrophil/lymphocyte ratio for efficacy of preoperative chemotherapy in triple-negative breast cancer
-
Asano Y, Kashiwagi S, Onoda N, et al. Predictive value of neutrophil/lymphocyte ratio for efficacy of preoperative chemotherapy in triple-negative breast cancer. Ann Surg Oncol 2016;23:1104–10.
-
(2016)
Ann Surg Oncol
, vol.23
, pp. 1104-1110
-
-
Asano, Y.1
Kashiwagi, S.2
Onoda, N.3
-
44
-
-
0021330196
-
Normal values for peripheral blood white cell counts in women of four different ethnic origins
-
Bain B, Seed M, Godsland I. Normal values for peripheral blood white cell counts in women of four different ethnic origins. J Clin Pathol 1984;37:188–93.
-
(1984)
J Clin Pathol
, vol.37
, pp. 188-193
-
-
Bain, B.1
Seed, M.2
Godsland, I.3
-
45
-
-
84903549095
-
Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer
-
Cihan YB, Arslan A, Cetindag MF, Mutlu H. Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer. Asian Pac J Cancer Prev 2014;15:4225–31.
-
(2014)
Asian Pac J Cancer Prev
, vol.15
, pp. 4225-4231
-
-
Cihan, Y.B.1
Arslan, A.2
Cetindag, M.F.3
Mutlu, H.4
-
46
-
-
84952665646
-
Neutrophil/lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
-
Suppan C, Bjelic-Radisic V, La Garde M, et al. Neutrophil/lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy. BMC Cancer 2015;15:1027.
-
(2015)
BMC Cancer
, vol.15
, pp. 1027
-
-
Suppan, C.1
Bjelic-Radisic, V.2
La Garde, M.3
-
47
-
-
84945475726
-
Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
-
Restivo A, Cocco IM, Casula G, et al. Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer. Br J Cancer 2015;113:1133–9.
-
(2015)
Br J Cancer
, vol.113
, pp. 1133-1139
-
-
Restivo, A.1
Cocco, I.M.2
Casula, G.3
|